Jump to:
Bsf Enterprise PLC Fundamentals
Company Name | Bsf Enterprise PLC | Last Updated | 2024-12-20 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
Shares in Issue | 103.337 m | Market Cap | £2.45 m |
---|
PE Ratio | 0.00 | Dividend per Share | 0 |
---|
Dividend Yield | 0 | Dividend Cover | 0 |
---|
EPS | -£0.02 | EPS Growth (%) | 0 |
---|
PEG | 0 | DPS Growth (%) | 0 |
---|
Debt Ratio | 0.0274 | Debt Equity Ratio | 0.0093 |
---|
Asset Equity Ratio | 1.0769 | Cash Equity Ratio | 0.3439 |
---|
Quick Ratio | 5.8212 | Current Ratio | 6.44 |
---|
Price To Book Value | 0.6144 | ROCE | 0 |
---|
Bsf Enterprise PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
Bsf Enterprise PLC Company Financials
Assets | 2023 | 2022 | 2021 |
---|
Tangible Assets | £252,833.00 | £297,048.00 | 0 |
Intangible Assets | £2.49 m | £2.49 m | 0 |
Investments | 0 | 0 | 0 |
Total Fixed Assets | £2.74 m | £2.78 m | 0 |
Stocks | £45,811.00 | £21,855.00 | 0 |
Debtors | £89,934.00 | £77,985.00 | 0 |
Cash & Equivalents | £2.32 m | £1.06 m | £359,868.00 |
Other Assets | 0 | 0 | 0 |
Total Assets | £5.26 m | £4.03 m | £401,446.00 |
Liabilities | 2023 | 2022 | 2021 |
---|
Creditors within 1 year | £303,620.00 | £278,576.00 | £36,630.00 |
Creditors after 1 year | £98,007.00 | £170,896.00 | 0 |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | £401,627.00 | £449,472.00 | £36,630.00 |
Net assets | £4.86 m | £3.58 m | £364,816.00 |
Equity | 2023 | 2022 | 2021 |
---|
Called up share capital | £1.03 m | £859,869.00 | £203,400.00 |
Share Premium | £6.29 m | £3.71 m | £407,984.00 |
Profit / Loss | -£1.58 m | -£929,432.00 | -£58,325.00 |
Other Equity | £4.86 m | £3.58 m | £364,816.00 |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | £4.86 m | £3.58 m | £364,816.00 |
Ratios | 2023 | 2022 | 2021 |
---|
Debt Ratio | £0.02 | £0.04 | 0 |
Debt-to-Equity | £0.02 | £0.04 | 0 |
Assets / Equity | 1.0769 | 1.0769 | 1.0769 |
Cash / Equity | 0.3439 | 0.3439 | 0.3439 |
EPS | -£0.02 | -£0.02 | £-0.00 |
Cash Flow | 2023 | 2022 | 2021 |
---|
Cash from operating activities | -£1.38 m | -£667,239.00 | -£85,193.00 |
Cashflow before financing | £1.32 m | £699,911.00 | -£85,193.00 |
Increase in Cash | £1.26 m | £701,661.00 | -£85,193.00 |
Income | 2023 | 2022 | 2021 |
---|
Turnover | £12,942.00 | 0 | 0 |
Cost of sales | £71,324.00 | 0 | 0 |
Gross Profit | -£58,382.00 | 0 | 0 |
Operating Profit | -£1.57 m | -£927,322.00 | -£58,325.00 |
Pre-Tax profit | -£1.58 m | -£929,432.00 | -£58,325.00 |
Bsf Enterprise PLC Company Background
Sector | Healthcare |
---|
Activities | BSF Enterprise PLC provides investment opportunities in the United Kingdom. Its activity is to undertake the acquisition of businesses in the biotechnology, marketing, and e-commerce sectors. |
---|
Latest Interim Date | 11 Jun 2024 |
---|
Latest Fiscal Year End Date | 31 Jan 2024 |
---|
Bsf Enterprise PLC Directors
Appointed | Name | Position |
---|
2024-06-17 | Mr. Geoffrey Robert Baker | Executive Director,Company Secretary |
2024-01-31 | Ms. Min Yang | Non-Executive Director,Chairman |
2024-01-31 | Professor Che John Connon | Executive Director,Chief Executive Officer |
Bsf Enterprise PLC Contact Details
Bsf Enterprise PLC Advisors